Authors/Disclosures
|
Sid Gilman, MD, FAAN
|
Dr. Gilman has nothing to disclose. |
|
Gregor K. Wenning, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Phillip A. Low, MD, FAAN
(Mayo Clinic)
|
Dr. Low has nothing to disclose. |
|
|
No disclosure on file |
|
David J. Brooks, MD, DSc, FRCP
(Imperial College London)
|
No disclosure on file |
|
Christopher Mathias
(St. Mary's Hospital)
|
No disclosure on file |
|
John Q. Trojanowski, MD, PhD
(University of PA School of Med)
|
Dr. Trojanowski has nothing to disclose. |
|
Nicholas W. Wood
(National Hospital for Neuro.)
|
No disclosure on file |
|
Carlo Colosimo, MD
(Universita La Sapienza)
|
No disclosure on file |
|
Alexandra Durr, MD
(Salpetriere Hospital - Universite Pierre Et Marie Curie)
|
The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC. |
|
Clare J. Fowler, FRCP
(Natl Hospital for Neurology and Neurosurgery)
|
No disclosure on file |
|
Horacio C. Kaufmann, MD, FAAN
(NYU Langone Health - NYU Dysautonomia Center)
|
Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parexel. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care. |
|
Thomas Klockgether, MD, FAAN
(University Hospital Neurology)
|
No disclosure on file |
|
Andrew J. Lees, MD, FRCP
(Reta Lila Weston Institute of Neurological Studies, IoN, UCL)
|
Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Britannia. Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Bial Pharma. |
|
Werner Poewe, MD
(University Hospital of Neurology)
|
Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities. |
|
Niall P. Quinn, MD, FAAN
(Institute of Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
David Robertson, MD
(Vanderbilt University AA 3228 MCN)
|
No disclosure on file |
|
Paola Sandroni, MD, PhD, FAAN
(Mayo Clinic)
|
Dr. Sandroni has nothing to disclose. |
|
Klaus Seppi, MD
|
Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO . Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Seppi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Seppi has received research support from MJFF. The institution of Dr. Seppi has received research support from EU. The institution of Dr. Seppi has received research support from FWF Austrian Science Fund,. |
|
Marie Vidailhet, MD, PhD
(Salpetriere Hospital)
|
No disclosure on file |